GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...

Frontline social care workers will also be eligible, as well as people who provide care for elderly or disabled people.

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

We are stronger when we are all protected against respiratory diseases,” said Dr. Tomas Aragon, public health officer for ...

As the 2024-2025 respiratory virus season gets under way, statewide infectious disease experts urge everyone in Oregon to ...

Global Respiratory Syncytial Virus Therapeutics Market was valued at approximately USD 5.88 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.82% over the forecast ...

caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older and in individuals 50 through 59 who are at increased risk for LRTD caused by RSV. The data were presented as a ...

Oregon health officials want to make sure everyone is safe and protected this respiratory virus season with vaccinations and ...

The new, free vaccine, Beyfortus, will be available to children up to 24 months old through their health care provider or at ...

Oregon public health officials are asking Oregonians to take steps to protect themselves and others from the slew of ...

The arrival of cooler weather and people gathering indoors can lead to the increased spread of COVID-19, influenza and ...

As the 2024-2025 respiratory virus season gets under way, statewide infectious disease experts urge everyone in Oregon ...